Recent advances in tumor necrosis factor and CD40 signaling

Current Opinion in Genetics and Development

Volumn 6, Issue 1, 1996, Pages 39-44

  Tewari, Muneesh ^a   Dixit, Vishva M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE RECEPTOR; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030044815     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(96)90008-8     Document Type: Article

References (19)

1. Beutler B, and Van Huffel C: Unraveling function in the TNF ligand and receptor families. Science 1994, 264:667-668.
2. Tartaglia LA, Goeddel DV: Two TNF receptors. Immunol Today 1992, 13:151-153.
3. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, Van Kooten C, Liu YJ, Roussel F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 1994, 12:881-922.
4. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994, 76:959-962.
5. Heller RA, Kronke M: Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 1994, 126:5-9.
6. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994, 12:141-179.
7. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994, 10:405-455.
8. Laegreid A, Medvedev A, Nonstad U, Bombara MP, Ranges G, Sundan A, Espevik T: Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor kappa B and induction of human cytomegalovirus enhancer. J Biol Chem 1994, 269:7785-7791.
9. Medvedev AE, Sundan A, Espevik T: involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities. Eur J Immunol 1994, 24:2842-2849.
10. Rothe M, Wong SC, Henzel WJ, Goeddel DV: A novel family of putative signal transducers associated with the cytoplasmic domain of the 75kDa tumor necrosis factor receptor. Cell 1994, 78:681-692. A combination of co-immunoprecipitation/biochemical purification and yeast two-hybrid screening methods was used to identify TRAF1 and TRAF2, two candidate signaling molecules that associate with the cytoplasmic segment of TNFR2. Both molecules contain a novel region of homology designated the TRAF domain. This paper represents the first identification of proteins that associate with the signaling domain of TNFR2.
11. Tartaglia LA, Rothe M, Hu YF, Goeddel DV: Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993, 73:213-216.
12. Heller RA, Song K, Fan N, Chang DJ: The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 1992, 70:47-56.
13. Bigda J, Beletsky I, Brakebusch C, Varfolomeev Y, Engelmann H, Bigda J, Holtmann H, Wallach D: Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J Exp Med 1994, 180:445-460.
14. Duvall E, Wyllie AH: Death and the cell. Immunology Today 1986, 7:115-119.
15. Ellis HM, Horvitz HR: Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cell 1986, 44:817-829.
16. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993, 75:641-652.
17. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, et al.: A novel heterodimeric cysteine protease is required for interleukln-1 β processing in monocytes. Nature 1992, 356:768-774.
18. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Ness KV, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA et al.: Molecular cloning of the interleukln-1 β converting enzyme. Science 1992, 256:97-100.
19. Kumar S: ICE-like proteases in apoptosis. Trends Biochem Sci 1995, 20:198-202.